Caption Management’s Kura Oncology KURA Stock Holding History

Caption Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$57.7K	–	1864
2025 Q2	$57.7K	Buy	+10,000	New	+$61.3K	﹤0.01%	1341
2025 Q1	–	Sell	-25,000	Closed	-$218K	–	1810
2024 Q4	$218K	Buy	+25,000	New	+$360K	﹤0.01%	1262
2022 Q4	–	Sell	-20,000	Closed	-$274K	–	1506
2022 Q3	$274K	Sell	20,000 -10,000	-33%	-$154K	﹤0.01%	1200
2022 Q2	$550K	Sell	30,000 -30,000	-50%	-$432K	0.01%	1052
2022 Q1	$963K	Sell	60,000 -14,900	-20%	-$215K	0.01%	988
2021 Q4	$1.05M	Buy	74,900 +44,900	+150%	+$727K	0.01%	1029
2021 Q3	$562K	Buy	30,000 +7,500	+33%	+$141K	0.01%	1178
2021 Q2	$469K	Buy	+22,500	New	+$559K	0.01%	1053

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Caption Management's KURA Position: Q3 2023 in Review

Caption Management sold out of Kura Oncology (KURA) in Q3 2023, closing a stake of 111,023 shares — an estimated $1.17M sold.

Caption Management first reported a position in KURA in Q4 2020 and held it in 6 quarters. The position peaked at $2.2M in Q4 2021. 133 funds tracked by Wall St. Rank hold KURA as of Q3 2023.

Caption Management reported no remaining Kura Oncology position as of Q3 2023 after selling out during the quarter.
Caption Management sold 111,023 Kura Oncology shares in Q3 2023, an estimated $1.17M.
Caption Management first reported a position in Kura Oncology in Q4 2020 and held it in 6 quarters.
Caption Management's Kura Oncology position peaked at $2.2M in Q4 2021.
133 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2023.

Based on Caption Management's 13F filing for Q3 2023, filed 14 Nov 2023.